Insider Transactions

What ArriVent BioPharma Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	0	1
Total trades	0	1

Shares traded

	3 months	12 months
Acquired	0	0
Disposed	0	555,555
Net activity	+0	−555,555

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Hillhouse Investment MANAGEMENT, Ltd.	10% owner	Dec 10	Open-market sale · S	−555,555	$23.37	−$13M	3,929,117
LaChapelle Robin	Chief Operating Officer	Jul 11	Exercise / conversion · M	+2,600	$2.28	+$5.93K	129,233
LaChapelle Robin	Chief Operating Officer	Jul 11	Exercise / conversion · M	+2,050	$2.28	+$4.67K	126,633
LaChapelle Robin	Chief Operating Officer	Jul 11	Exercise / conversion · M	+6,503	$2.28	+$14.8K	135,736
LaChapelle Robin	Chief Operating Officer	Sep 19	Exercise / conversion · M	+2,867	$2.28	+$6.54K	102,584
LaChapelle Robin	Chief Operating Officer	Sep 19	Exercise / conversion · M	+2,700	$6.24	+$16.8K	99,717
LaChapelle Robin	Chief Operating Officer	Sep 19	Exercise / conversion · M	+12,364	$3.65	+$45.1K	124,583
LaChapelle Robin	Chief Operating Officer	Sep 19	Exercise / conversion · M	+2,471	$2.28	+$5.63K	112,219
LaChapelle Robin	Chief Operating Officer	Sep 19	Exercise / conversion · M	+7,164	$2.28	+$16.3K	109,748
Healy James	Director	Jan 30	Open-market buy · P	+444,444	$18.00	+$8M	1,696,752
Healy James	Director	Jan 30	Derivative Conversion · C	+1,252,308	—	—	1,252,308
Orbimed Advisors Llc	Director	Jan 30	Open-market buy · P	+222,222	$18.00	+$4M	1,513,664
Orbimed Advisors Llc	Director	Jan 30	Open-market buy · P	+222,222	$18.00	+$4M	1,513,664
Orbimed Advisors Llc	Director	Jan 30	Derivative Conversion · C	+469,615	—	—	1,291,442
Orbimed Advisors Llc	Director	Jan 30	Derivative Conversion · C	+469,615	—	—	1,291,442
Orbimed Advisors Llc	Director	Jan 30	Derivative Conversion · C	+821,827	—	—	821,827
Orbimed Advisors Llc	Director	Jan 30	Derivative Conversion · C	+821,827	—	—	821,827
Hillhouse Investment MANAGEMENT, Ltd.	10% owner	Jan 30	Open-market buy · P	+555,555	$18.00	+$10M	4,484,672
Hillhouse Investment MANAGEMENT, Ltd.	10% owner	Jan 30	Derivative Conversion · C	+313,076	—	—	3,929,117
Hillhouse Investment MANAGEMENT, Ltd.	10% owner	Jan 30	Derivative Conversion · C	+3,616,041	—	—	3,616,041

Page 1 of 2 · showing the 20 most recent Sign up free to view all 26 transactions and filter by insider →